Xcout Intel
Applied Therapeutics Inc.
Applied Therapeutics, Inc. is a biopharmaceutical company headquartered in New York City, focused on developing novel product candidates targeted at disease targets involving enzyme and metabolic pathways.
Subscribe to see Applied Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Applied Therapeutics Inc. at a glance
Applied Therapeutics Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $100M in February 2024.
Applied Therapeutics Inc. funding rounds
The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $100M | — | |
| SEC Form D filing | $30M | — | |
| SEC Form D filing | $20M | — | |
| SEC Form D filing | $27.2M | — | |
| SEC Form D filing | $6M | — | |
| SEC Form D filing | $6.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Applied Therapeutics Inc. news
Investors
Applied Therapeutics Inc. competitors
A few of Applied Therapeutics Inc.'s closest competitors — see the full list of competitors and alternatives →
Amicus Therapeutics, Inc. is an American biopharmaceutical company focused on discovering and delivering advanced therapies for rare diseases. The company is publicly traded on Nasdaq and maintains its global corporate headquarters in Princeton, New Jersey.
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.
Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, focused on identifying, developing, and delivering life-changing therapies for people living with rare diseases.
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders.
Ambros Therapeutics is a clinical-stage biotechnology company headquartered in Irvine, California, focused on the development of innovative therapeutics.
Amicus Therapeutics, a subsidiary of BioMarin Pharmaceutical Inc., is a biotechnology company that researches and delivers medicines for individuals living with genetically defined rare diseases. The company provides patient advocacy and support services alongside its clinical development pipeline.
Get Applied Therapeutics Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Applied Therapeutics Inc. in Xcout Intel
- 7 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access